Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Uptune programme

- PMLiVE

Amiculum joins Bionow: supporting collaboration across the life sciences sector in the North of the UK

We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role in bringing together life sciences organizations across the North of the...

Amiculum

- PMLiVE

Amiculum reaffirms presence in Dundee with new office and continued academic partnership

Amiculum is pleased to announce the relocation of its Dundee team to a new, state-of-the-art facility at the Dundee Life Sciences Innovation Hub, an environment designed to accelerate scientific progress...

Amiculum

- PMLiVE

British Chambers of Commerce partners with Singapore to scale up UK imports

The Singapore Life Sciences Trade Accelerator six-month pilot programme aims to increase export opportunities

- PMLiVE

Merck KGaA given FDA Fast Track designation for generalised myasthenia gravis drug

Cladribine capsules could become the first ever oral treatment for gMG

- PMLiVE

New centre for life sciences launched in London

Victoria House is a state-of-the-art life sciences hub

- PMLiVE

BioNTech announces £1bn UK investment to boost regional R&D presence

The UK government has also agreed to award the company a grant of up to £129m

Map Treatment Pathways Virtually – Engaging Your Advisors Creatively

Optimize product strategy! Discover how virtual profiling can accurately map treatment pathways and pinpoint opportunities for your innovations while engaging your advisors in a creative way!

Impetus Digital

- PMLiVE

Eli Lilly and Creyon Bio enter oligonucleotide therapy partnership worth over $1bn

The companies will aim to develop RNA-targeted drugs for a broad range of diseases

- PMLiVE

Merck KGaA expands rare tumour portfolio with $3.9bn SpringWorks acquisition

SpringWorks’ Gomekli was approved by the FDA earlier this year to treat patients with NF1

- PMLiVE

Merck KGaA’s Mavenclad tablets recommended by NICE for wider MS use

The neurological disorder affects more than 150,000 people in the UK

Establishing Remote Work Norms – Building Company Culture Virtually

Ready to redefine remote work in pharma? The second step is establishing clear norms, processes, and expectations that resonate with your team. Dive into our series for more tips on...

Impetus Digital

- PMLiVE

Merck KGaA/Abbisko share positive phase 3 results for pimicotinib in rare tumour type

The companies entered into a licensing agreement for the candidate in December last year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links